NasdaqGM - Nasdaq Real Time Price USD

Relay Therapeutics, Inc. (RLAY)

Compare
6.27 -0.03 (-0.47%)
As of 10:20 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
35,327.00
25,546.00
1,381.00
3,029.00
82,654.00
--
Operating Expense
404,764.00
404,968.00
312,333.00
230,036.00
138,450.00
--
Operating Income
-369,437.00
-379,422.00
-310,952.00
-227,007.00
-55,796.00
--
Net Non Operating Interest Income Expense
33,055.00
31,045.00
8,786.00
830.00
3,400.00
--
Other Income Expense
7,261.00
6,404.00
11,657.00
-137,695.00
-16.00
--
Pretax Income
-329,121.00
-341,973.00
-290,509.00
-363,872.00
-52,412.00
--
Net Income Common Stockholders
-329,121.00
-341,973.00
-290,509.00
-363,872.00
-230,201.00
--
Diluted NI Available to Com Stockholders
-329,121.00
-341,973.00
-290,509.00
-363,872.00
-230,201.00
--
Basic EPS
-2.63
--
-2.59
-3.82
-5.40
-17.59
Diluted EPS
-2.63
--
-2.59
-3.82
-5.40
-17.59
Basic Average Shares
124,957.06
--
112,233.65
95,136.72
42,619.58
4,281.17
Diluted Average Shares
124,957.06
--
112,233.65
95,136.72
42,619.58
4,281.17
Total Operating Income as Reported
-362,186.00
-373,000.00
-299,275.00
-364,698.00
-55,796.00
--
Total Expenses
404,764.00
404,968.00
312,333.00
230,036.00
138,450.00
--
Net Income from Continuing & Discontinued Operation
-329,121.00
-341,973.00
-290,509.00
-363,872.00
-52,412.00
--
Normalized Income
-336,372.00
-348,395.00
-302,186.00
-226,181.00
-52,412.00
--
Interest Income
33,055.00
31,045.00
8,786.00
830.00
3,400.00
--
Net Interest Income
33,055.00
31,045.00
8,786.00
830.00
3,400.00
--
EBIT
-369,437.00
-379,422.00
-310,952.00
-227,007.00
-55,796.00
--
EBITDA
-363,970.00
-374,153.00
-306,822.00
-223,082.00
-52,247.00
--
Reconciled Depreciation
5,467.00
5,269.00
4,130.00
3,925.00
3,549.00
--
Net Income from Continuing Operation Net Minority Interest
-329,121.00
-341,973.00
-290,509.00
-363,872.00
-52,412.00
--
Total Unusual Items Excluding Goodwill
7,251.00
6,422.00
11,677.00
-137,691.00
--
--
Total Unusual Items
7,251.00
6,422.00
11,677.00
-137,691.00
--
--
Normalized EBITDA
-371,221.00
-380,575.00
-318,499.00
-85,391.00
-52,247.00
--
12/31/2019 - 7/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RVMD Revolution Medicines, Inc.
38.44
-0.23%
 
KYMR Kymera Therapeutics, Inc.
29.87
-1.16%
 
TNGX Tango Therapeutics, Inc.
8.65
+1.29%
 
ORIC ORIC Pharmaceuticals, Inc.
6.98
+0.94%
 
NKTX Nkarta, Inc.
5.87
+0.17%
 
OLMA Olema Pharmaceuticals, Inc.
10.85
-3.21%
 
EXAI Exscientia plc
5.13
-1.73%
 
PCVX Vaxcyte, Inc.
76.25
-3.20%
 
ABSI Absci Corporation
3.0800
+0.99%
 
MGX Metagenomi, Inc.
3.7700
0.00%